Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

58.70 +1.11 (+1.93%)
Streaming Delayed Price Updated: 12:53 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 734,864
Open 57.63
Bid (Size) 58.65 (200)
Ask (Size) 58.75 (300)
Prev. Close 57.59
Today's Range 56.47 - 59.75
52wk Range 11.85 - 57.80
Shares Outstanding 85,860,949
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
What to Know About This Fund’s $15.5 Million Sale of Liquidia as Shares Skyrocket Nearly 260% ↗
Liquidia develops therapies for rare cardiopulmonary diseases, leveraging proprietary drug delivery technologies in the U.S. market. 
Via The Motley Fool
News headline image
Liquidia (LQDA) Q1 2026 Earnings Transcript ↗
Liquidia (LQDA) Q1 2026 Earnings Transcript 
Via The Motley Fool

Performance

YTD
+86.9%
+86.9%
1 Month
+51.1%
+51.1%
3 Month
+46.1%
+46.1%
6 Month
+107.3%
+107.3%
1 Year
+267.1%
+267.1%

More News

Read More
News headline image
Liquidia Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Liquidia Corp (NASDAQ:LQDA) Smashes Q1 Estimates as YUTREPIA Adoption Accelerates ↗
Via Chartmill
Liquidia Corp (NASDAQ:LQDA): High Growth Momentum Setup Nears Breakout ↗
Via Chartmill
Liquidia Corp (NASDAQ:LQDA) Presents a High-Growth Momentum and Technical Setup ↗
Via Chartmill
Liquidia Corp (NASDAQ:LQDA) Shows High-Growth Momentum and Minervini Trend Alignment ↗
Via Chartmill
News headline image
Liquidia Corporation Reports First Quarter 2026 Financial Results
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Liquidia Corporation to Participate in Upcoming Investor Conferences
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
From Liquidia Technologies, Inc.
Via GlobeNewswire
Liquidia Corp (NASDAQ:LQDA) Reports Q4 2025 Profitability and Revenue Beat Driven by YUTREPIA Launch ↗
Via Chartmill
News headline image
Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Liquidia Corporation to Participate in Upcoming Investor Conferences
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Liquidia Stock Up 135% as Insider Sells $1.3 Million in Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Dave Stock Soars 150% in a Year as Newly Disclosed $7 Million Buy Signals Confidence in Fintech Upstart ↗
Via The Motley Fool
Topics ETFs
News headline image
Liquidia (LQDA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Moonshot Medicine: United Therapeutics Surges on Record Earnings and TreSMI Breakthrough
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
United Therapeutics (UTHR) Deep Dive: Strong Q4 and the ‘Inhalation Evolution’
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property

Frequently Asked Questions

Is Liquidia Corporation - Common Stock publicly traded?
Yes, Liquidia Corporation - Common Stock is publicly traded.
What exchange does Liquidia Corporation - Common Stock trade on?
Liquidia Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liquidia Corporation - Common Stock?
The ticker symbol for Liquidia Corporation - Common Stock is LQDA on the Nasdaq Stock Market
What is the current price of Liquidia Corporation - Common Stock?
The current price of Liquidia Corporation - Common Stock is 58.70
When was Liquidia Corporation - Common Stock last traded?
The last trade of Liquidia Corporation - Common Stock was at 05/14/26 12:53 PM ET
What is the market capitalization of Liquidia Corporation - Common Stock?
The market capitalization of Liquidia Corporation - Common Stock is 5.04B
How many shares of Liquidia Corporation - Common Stock are outstanding?
Liquidia Corporation - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS